Edition:
United States

Evoke Pharma Inc (EVOK.OQ)

EVOK.OQ on NASDAQ Stock Exchange Capital Market

2.75USD
2:43pm EDT
Change (% chg)

$-0.02 (-0.72%)
Prev Close
$2.77
Open
$2.78
Day's High
$2.78
Day's Low
$2.73
Volume
1,340
Avg. Vol
14,515
52-wk High
$4.09
52-wk Low
$1.86

Chart for

About

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in... (more)

Overall

Beta: 1.40
Market Cap(Mil.): $45.46
Shares Outstanding(Mil.): 16.77
Dividend: --
Yield (%): --

Financials

  EVOK.OQ Industry Sector
P/E (TTM): -- 29.92 34.14
EPS (TTM): -0.60 -- --
ROI: -101.27 13.64 13.17
ROE: -148.67 15.43 15.14

BRIEF-Evoke Pharma Posts Loss Of $0.13 Per Share in Q1

* EVOKE PHARMA REPORTS FIRST QUARTER 2018 RESULTS AND HIGHLIGHTS

May 14 2018

BRIEF-Evoke Pharma Granted Gender Specific Patent For Gimoti In Mexico

* EVOKE GRANTED GENDER SPECIFIC PATENT FOR GIMOTI™ IN MEXICO Source text for Eikon: Further company coverage:

May 10 2018

BRIEF-Evoke Announces Agreement With Mallinckrodt To Amend Milestone Payments

* EVOKE ANNOUNCES AGREEMENT WITH MALLINCKRODT TO AMEND MILESTONE PAYMENTS

Mar 26 2018

BRIEF-Evoke Pharma Q4 Loss Per Share $0.02

* EVOKE PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

Mar 07 2018

Competitors

Earnings vs. Estimates